Evidence map›Paper›PMID 39582610›Full record

ArticleWorld journal of clinical oncology2024

Primary pancreatic lymphoma: A case report and review of literature.

Marko M Stojanovic, Vesna Brzacki, Goran Marjanovic, Milica Nestorovic, Jelena Zivadinovic, Miljan Krstic, Marko Gmijovic, Ilija Golubovic, Svetlana Jovanovic, Miroslav P Stojanovic and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marko M StojanovicDepartment of Gastroenterology and Hepatology Clinic, University Clinical Center Nis, Medical Faculty University of Nis, Nis 18000, Serbia.
Vesna BrzackiDepartment of Gastroenterology and Hepatology Clinic, University Clinical Center Nis, Medical Faculty University of Nis, Nis 18000, Serbia.
Goran MarjanovicImmunology, Medical Faculty University of Nis, Nis 18000, Serbia.
Milica NestorovicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia.
Jelena ZivadinovicClinic of Aneasthesiology and Intensive Therapy, University Clinical Center Nis, University of Nis, Nis 18000, Serbia.
Miljan KrsticDepartment of Pathology, Medical Faculty University of Nis, Nis 18000, Serbia.
Marko GmijovicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia.
Ilija GolubovicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia.
Svetlana JovanovicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia.
Miroslav P StojanovicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia. drmiroslavstojanovic@gmail.com.
Katarina TerzicClinic for Digestive Surgery, University Clinical Center, Medical Faculty University of Nis, Nis 18000, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary pancreatic lymphoma (PPL) is a rare tumor that mimics pancreatic adenocarcinoma, leading to diagnostic and therapeutic challenges. PPL accounts for 0.2% of all pancreatic tumors and is typically treated with chemotherapy. However, the long-term survival rates for PPL with chemotherapy and radiotherapy alone are unsatisfactory. Due to the improvements in pancreatic surgery, there is a need to reevaluate the treatment strategies for PPL. CASE SUMMARY: A 62-year-old male presented to our clinic. A biopsy was unsuccessful, and the imaging was suggestive of pancreatic adenocarcinoma. Therefore, subtotal splenopancreatectomy was performed and histopathology was performed. He was then diagnosed with primary pancreatic diffuse large B-cell lymphoma. He received adjuvant chemotherapy and radiotherapy. Currently, the patient is alive with no evidence of disease 36 months after surgery.

conclusionThe potential role of surgery in the treatment of PPL should be emphasized and added in the management protocol of early stage lymphoma.

Indexed as

Case reportLymphomaPancreasPrimaryStrategySurgeryTreatment

Identifiers

PMID39582610
PMCPMC11514422

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.